There have been 50 recent insider transactions recorded for Tarsus Pharmaceuticals, Inc. (TARS), including 9 buys and 38 sells. Total insider buying was valued at RSU Award and total insider selling at $8.71M.
Notable insiders with recent activity include Neervannan Seshadri, Farrow Jeffrey S, Mottiwala Aziz. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — TARS
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-03-20 |
Neervannan Seshadri |
Chief Operating Officer |
Informative Sell |
2,989 |
$66.75 |
$199.52K |
82,791 |
| 2026-03-19 |
Farrow Jeffrey S |
See Remarks |
Informative Sell |
2,186 |
$67.00 |
$146.46K |
43,316 |
| 2026-03-19 |
Mottiwala Aziz |
Chief Commercial Officer |
Informative Sell |
4,440 |
$67.00 |
$297.48K |
61,480 |
| 2026-03-19 |
Neervannan Seshadri |
Chief Operating Officer |
Informative Sell |
4,589 |
$67.00 |
$307.46K |
85,780 |
| 2026-03-19 |
Azamian Bobak R. |
President/ceo and Board Chair |
Informative Sell |
11,964 |
$67.00 |
$801.59K |
33,421 |
| 2026-03-19 |
Whitfield Dianne C. |
Chief Human Resources Officer |
Informative Sell |
4,174 |
$67.00 |
$279.66K |
35,028 |
| 2026-03-19 |
Wahl Bryan |
General Counsel |
Informative Sell |
4,231 |
$67.00 |
$283.48K |
63,959 |
| 2026-03-19 |
Lin Elizabeth Yeu |
Chief Medical Officer |
Informative Sell |
390 |
$67.00 |
$26.13K |
23,308 |
| 2026-03-18 |
Farrow Jeffrey S |
See Remarks |
Informative Sell |
2,133 |
$68.71 |
$146.56K |
45,502 |
| 2026-03-18 |
Mottiwala Aziz |
Chief Commercial Officer |
Informative Sell |
4,330 |
$68.71 |
$297.51K |
65,920 |
| 2026-03-18 |
Neervannan Seshadri |
Chief Operating Officer |
Informative Sell |
3,610 |
$68.71 |
$248.04K |
90,369 |
| 2026-03-18 |
Azamian Bobak R. |
President/ceo and Board Chair |
Informative Sell |
11,667 |
$68.71 |
$801.64K |
45,385 |
| 2026-03-18 |
Whitfield Dianne C. |
Chief Human Resources Officer |
Informative Sell |
4,071 |
$68.71 |
$279.72K |
39,202 |
| 2026-03-18 |
Wahl Bryan |
General Counsel |
Informative Sell |
4,125 |
$68.71 |
$283.43K |
68,190 |
| 2026-03-18 |
Lin Elizabeth Yeu |
Chief Medical Officer |
Informative Sell |
379 |
$68.71 |
$26.04K |
23,698 |
| 2026-03-17 |
Farrow Jeffrey S |
See Remarks |
Informative Sell |
2,111 |
$69.42 |
$146.55K |
47,635 |
| 2026-03-17 |
Mottiwala Aziz |
Chief Commercial Officer |
Informative Sell |
4,286 |
$69.42 |
$297.53K |
70,250 |
| 2026-03-17 |
Neervannan Seshadri |
Chief Operating Officer |
Informative Sell |
3,125 |
$69.42 |
$216.94K |
93,979 |
| 2026-03-17 |
Azamian Bobak R. |
President/ceo and Board Chair |
Informative Sell |
10,972 |
$69.42 |
$761.68K |
57,052 |
| 2026-03-17 |
Whitfield Dianne C. |
Chief Human Resources Officer |
Informative Sell |
4,029 |
$69.42 |
$279.69K |
43,273 |
| 2026-03-17 |
Wahl Bryan |
General Counsel |
Informative Sell |
4,084 |
$69.42 |
$283.51K |
72,315 |
| 2026-03-17 |
Lin Elizabeth Yeu |
Chief Medical Officer |
Informative Sell |
375 |
$69.42 |
$26.03K |
24,077 |
| 2026-03-16 |
Link William J Phd |
Director |
Informative Sell |
493 |
$69.75 |
$34.39K |
116,332 |
| 2026-03-15 |
Farrow Jeffrey S |
See Remarks |
Option Exercise (Sell) |
5,022 |
- |
- |
15,067 |
| 2026-03-15 |
Mottiwala Aziz |
Chief Commercial Officer |
Option Exercise (Sell) |
4,790 |
- |
- |
- |
| 2026-03-15 |
Neervannan Seshadri |
Chief Operating Officer |
Option Exercise (Sell) |
5,097 |
- |
- |
- |
| 2026-03-15 |
Azamian Bobak R. |
President/ceo and Board Chair |
Option Exercise (Sell) |
11,300 |
- |
- |
- |
| 2026-03-15 |
Whitfield Dianne C. |
Chief Human Resources Officer |
Option Exercise (Sell) |
4,463 |
- |
- |
- |
| 2026-03-15 |
Wahl Bryan |
General Counsel |
Option Exercise (Sell) |
4,790 |
- |
- |
- |
| 2026-03-15 |
Lin Elizabeth Yeu |
Chief Medical Officer |
Option Exercise (Sell) |
2,511 |
- |
- |
7,534 |
| 2026-03-05 |
Farrow Jeffrey S |
See Remarks |
RSU Award |
19,306 |
- |
- |
19,306 |
| 2026-03-05 |
Mottiwala Aziz |
Chief Commercial Officer |
RSU Award |
19,306 |
- |
- |
19,306 |
| 2026-03-05 |
Neervannan Seshadri |
Chief Operating Officer |
RSU Award |
17,161 |
- |
- |
17,161 |
| 2026-03-05 |
Azamian Bobak R. |
President/ceo and Board Chair |
RSU Award |
60,776 |
- |
- |
60,776 |
| 2026-03-05 |
Whitfield Dianne C. |
Chief Human Resources Officer |
RSU Award |
17,161 |
- |
- |
17,161 |
| 2026-03-05 |
Wahl Bryan |
General Counsel |
RSU Award |
17,161 |
- |
- |
17,161 |
| 2026-03-05 |
Lin Elizabeth Yeu |
Chief Medical Officer |
RSU Award |
17,161 |
- |
- |
17,161 |
| 2026-03-04 |
Neervannan Seshadri |
Chief Operating Officer |
Informative Sell |
8,366 |
$76.67 |
$641.42K |
70,817 |
| 2026-02-18 |
Pyott David E I |
Director |
Unknown |
7,000 |
$12.97 |
$90.79K |
- |
| 2026-02-18 |
Pyott David E I |
Director |
RSU Award |
3,729 |
- |
- |
3,729 |
| 2026-01-02 |
Whitfield Dianne C. |
Chief Human Resources Officer |
Informative Sell |
893 |
$82.93 |
$74.06K |
23,393 |
| 2025-12-24 |
Azamian Bobak R. |
President/ceo and Board Chair |
Informative Sell |
557 |
$83.54 |
$46.53K |
857,991 |
| 2025-12-16 |
Lin Elizabeth Yeu |
Chief Medical Officer |
Informative Sell |
2,078 |
$79.50 |
$165.2K |
21,941 |
| 2025-12-16 |
Neervannan Seshadri |
Chief Operating Officer |
Gift (Received) |
475 |
- |
- |
475 |
| 2025-12-16 |
Whitfield Dianne C. |
Chief Human Resources Officer |
Informative Sell |
7,397 |
$80.10 |
$592.5K |
38,958 |
| 2025-12-15 |
Goodrich Katherine |
Director |
Option Exercise |
2,233 |
- |
- |
2,233 |
| 2025-12-15 |
Link William J Phd |
Director |
Informative Sell |
4,766 |
$81.50 |
$388.43K |
- |
| 2025-12-15 |
Lin Elizabeth Yeu |
Chief Medical Officer |
Option Exercise (Sell) |
6,819 |
- |
- |
20,459 |
| 2025-12-04 |
Azamian Bobak R. |
President/ceo and Board Chair |
Gift (Given) |
51,885 |
- |
- |
1,750 |
| 2025-09-24 |
Azamian Bobak R. |
President/ceo and Board Chair |
Informative Sell |
6,000 |
$55.37 |
$332.22K |
812,106 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
